Recently, VivaVision Biotech (VivaVision), a late clinical-stage, privately-held biotech company focused on developing innovative ophthalmic drugs, announced that it has received the written meeting ...
Bloodletting therapy is a key Ayurvedic treatment for anterior uveitis Leeches secrete bioactive compounds that reduce inflammation and pain Complementary therapies like Shirovirechana Nasya and ...
A 29-year-old woman was referred to Tufts Medical Center for undifferentiated bilateral anterior and intermediate uveitis.The ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Enrollment in the pivotal phase 3 trial ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. EyeGate Pharmaceuticals Inc. said that a late-stage study ...
Among patients with ankylosing spondylitis or undifferentiated spondyloarthritis, risk for anterior uveitis may hinge on the choice of biologic disease-modifying antirheumatic drug (bDMARD), a large ...
Dublin, March 19, 2024 (GLOBE NEWSWIRE) -- The "Global Anterior Uveitis Treatment Market by Treatment Type (Anti-Tumor Necrosis Factor Agents, Corticosteroids, Cycloplegic Agents), Distribution ...
Ankylosing spondylitis (AS) is a chronic spondyloarthropathy, manifested as inflammation of the spine, peripheral joints, entheses and the uvea. Ocular involvement occurs in 30–40% of patients.
SAN FRANCISCO, Sept. 18, 2019 /PRNewswire/ -- The global anterior uveitis treatment market size is expected to reach USD 418.23 million by 2026, according to a new report by Grand View Research, Inc., ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback